Torrent Pharmaceuticals (India) Today
| TORNTPHARM | 3,224 1.10 0.03% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Torrent Pharmaceuticals is trading at 3224.45 as of the 28th of November 2024. This is a 0.03 percent decrease since the beginning of the trading day. The stock's open price was 3225.55. Torrent Pharmaceuticals has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Torrent Pharmaceuticals Limited are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of October 2024 and ending today, the 28th of November 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Torrent Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange. The company has 338.44 M outstanding shares. More on Torrent Pharmaceuticals Limited
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Torrent Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Torrent Pharmaceuticals' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Torrent Pharmaceuticals or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| President USA | Sanjay Gupta | ||||
| Business Concentration | Pharmaceuticals, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Pharmaceuticals, Drug Manufacturers-Specialty & Generic, Healthcare (View all Sectors) | ||||
Torrent Pharmaceuticals' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Torrent Pharmaceuticals' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsTorrent Pharmaceuticals can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Torrent Pharmaceuticals' financial leverage. It provides some insight into what part of Torrent Pharmaceuticals' total assets is financed by creditors.
| |||||
Torrent Pharmaceuticals Limited (TORNTPHARM) is traded on National Stock Exchange of India in India and employs 15,718 people. Torrent Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 1.09 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Torrent Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Torrent Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Torrent Pharmaceuticals operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 338.44 M outstanding shares.
Torrent Pharmaceuticals Limited has accumulated about 379.8 M in cash with 32.66 B of positive cash flow from operations.
Check Torrent Pharmaceuticals Probability Of Bankruptcy
Ownership AllocationTorrent Pharmaceuticals shows a total of 338.44 Million outstanding shares. Torrent Pharmaceuticals has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 69.74 % of Torrent Pharmaceuticals outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Torrent Ownership Details
Torrent Pharmaceuticals Risk Profiles
Although Torrent Pharmaceuticals' alpha and beta are two of the key measurements used to evaluate Torrent Pharmaceuticals' performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.16 | |||
| Standard Deviation | 1.58 | |||
| Variance | 2.5 | |||
| Risk Adjusted Performance | (0.02) |
Torrent Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Torrent Pharmaceuticals without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Screener Now
Stock ScreenerFind equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. |
| All Next | Launch Module |
Torrent Pharmaceuticals Corporate Management
Elected by the shareholders, the Torrent Pharmaceuticals' board of directors comprises two types of representatives: Torrent Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Torrent. The board's role is to monitor Torrent Pharmaceuticals' management team and ensure that shareholders' interests are well served. Torrent Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Torrent Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
| MMS BE | VP Projects | Profile | |
| Jaydip Bhatt | Vice Resource | Profile | |
| Samir Mehta | Ex MD | Profile | |
| Kaushal CA | Vice Finance | Profile | |
| Chintan Trivedi | Company Officer | Profile |
Other Information on Investing in Torrent Stock
Torrent Pharmaceuticals financial ratios help investors to determine whether Torrent Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Torrent with respect to the benefits of owning Torrent Pharmaceuticals security.